Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of β3 adrenoceptor activation

Neuropsychopharmacology

Volumn 35, Issue 9, 2010, Pages 1886-1896

  Silberman, Yuval ^a   Ariwodola, Olusegun J ^a   Chappell, Ann M ^a   Yorgason, Jordan T ^a   Weiner, Jeff L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

anxiety; basolateral amygdala; BRL37344; GABAergic interneurons; IPSCs; norepinephrine

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; ANXIOLYTIC AGENT; CLONIDINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; PROPRANOLOL; (+)-(S)-5,5-DIMETHYLMORPHOLINYL-2-ACETIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADENOSINE-3',5'-CYCLIC PHOSPHOROTHIOATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; ETHANOLAMINE DERIVATIVE; MORPHOLINE DERIVATIVE; NUCLEOTIDE; PROTEIN KINASE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; DRUG ACTIVATION; DRUG EFFECT; ELECTROPHYSIOLOGY; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; HYPOTHESIS; INTERNEURON; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SYNAPSE; TRANQUILIZING ACTIVITY; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; DRUG THERAPY; EXPLORATORY BEHAVIOR; INHIBITORY POSTSYNAPTIC POTENTIAL; LOCOMOTION; METABOLISM; PATCH CLAMP TECHNIQUE; PROCEDURES; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CYCLIC AMP; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETHANOLAMINES; EVOKED POTENTIALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; LOCOMOTION; MALE; MICROINJECTIONS; MORPHOLINES; PATCH-CLAMP TECHNIQUES; PROPRANOLOL; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; SYNAPSES; THIONUCLEOTIDES;

EID: 77954756881     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.59     Document Type: Article

References (64)

1. Abraham PA, Xing G, Zhang L, Yu EZ, Post R, Gamble EH et al (2008). beta1- and beta2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala. Brain Res 1209: 65-73.
2. Aggleton JP, Burton MJ, Passingham RE (1980). Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta). Brain Res. 190: 347-368.
3. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE et al (1984). Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309: 163-165.
4. Ariwodola OJ, Weiner JL (2004). Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J Neurosci 24: 10679-10686.
5. Auger C, Marty A (2000). Quantal currents at single-site central synapses. J Physiol 526: 3-11.
6. Baker JG (2005). The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144: 317-322.
7. Berlau DJ, McGaugh JL (2006). Enhancement of extinction memory consolidation: the role of the noradrenergic and GABAergic systems within the basolateral amygdala. Neurobiol Learn Mem 86: 123-132.
8. Braga MF, Aroniadou-Anderjaska V, Xie J, Li H (2003). Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. J Neurosci 23: 442-452.
9. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23: 28-38.
10. Bueno CH, Zangrossi Jr H, Viana MB (2005). The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Braz J Med Biol Res 38: 1697-1701.
11. Claustre Y, Leonetti M, Santucci V, Bougault I, Desvignes C, Rouquier L et al (2008). Effects of the beta(3)-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile. Neuroscience 156: 353-364.
12. Consoli D, Leggio GM, Mazzola C, Micale V, Drago F (2007). Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/ anxiolytic drugs? Eur J Pharmacol 573: 139-147.
13. Daly JW, Padgett W, Creveling CR, Cantacuzene D, Kirk KL (1981). Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain. J Neurosci 1: 49-59.
14. Davis M, Rainnie D, Cassell M (1994). Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17: 208-214.
15. Doheny HC, Lynch CM, Smith TJ, Morrison JJ (2005). Functional coupling ofbeta3-adrenoceptors and large conductance calcium- activated potassium channels in human uterine myocytes. J Clin Endocrinol Metab 90: 5786-5796.
16. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD et al (2005). Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsycho- pharmacology 30: 657-668.
17. Engin E, Treit D (2008). The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 32: 1399-1419.
18. Fallon JH, Koziell DA, Moore RY (1978). Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180: 509-532.
19. Ferry B, Roozendaal B, McGaugh JL (1999). Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta- and alpha1-adrenoceptors. J Neurosci 19: 5119-5123.
20. File SE, Mabbutt PS, Hitchcott PK (1990). Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmaco- logy 102: 98-101.
21. File SE, Zangrossi Jr H (1993). 'One-trial tolerance' to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110: 240-244.
22. Gonzalez LE, Andrews N, File SE (1996). 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732: 145-153.
23. Holmes A, Rodgers RJ (1999). Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23: 971-980.
24. 2+-activated K+ channels. Am J Physiol Cell Physiol 295: C1344-C1353.
25. Isoardi NA, Bertotto ME, Martijena ID, Molina VA, Carrer HF. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs. Eur J Neurosci 26: 1036-1044.
26. Jia F, Pignataro L, Schofield CM, Yue M, Harrison NL, Goldstein PA (2005). An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons. J Neuro- physiol 94: 4491-4501.
27. Jiang X, Xing G, Yang C, Verma A, Zhang L, Li H (2009). Stress impairs 5-HT2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala. Neuropsy- chopharmacology 34: 410-423.
28. Kapur J, MacDonald RL (1996). Cyclic AMP-dependent protein kinase enhances hippocampal dentate granule cell GABAA receptor current. J Neurophysiol 76: 2626-2634.
29. Kaneko K, Tamamaki N, Owada H, Kakizaki T, Kume N, Totsuka M et al (2008). Noradrenergic excitation of a subpopula- tion of GABAergic cells in the basolateral amygdala via both activation of nonselective cationic conductance and suppression of resting K+ conductance: a study using glutamate decarboxylase 67-green fluorescent protein knock-in mice. Neuroscience 157: 781-797.
30. Kobayashi M, Hamada T, Kogo M, Yanagawa Y, Obata K, Kang Y. Developmental profile of GABAA-mediated synaptic transmission in pyramidal cells of the somatosensory cortex. Eur J Neurosci 28: 849-861.
31. Kullmann FA, Limberg BJ, Artim DE, Shah M, Downs TR, Contract D et al (2009). Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy. J Pharmacol Exp Ther 330: 704-717.
32. Lack AK, Ariwodola OJ, Chappell AM, Weiner JL, McCool BA (2008). Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala. Neuropharmacology 55: 661-668.
33. LaLumiere RT, Buen TV, McGaugh JL (2003). Post-training intra- basolateral amygdala infusions of norepinephrine enhance consolidation of memory for contextual fear conditioning. J Neurosci 23: 6754-6758.
34. Leibmann L, Karst H, Jöels M (2009). Effects of corticosterone and the β-agonist isoproterenol on glutamate receptor-mediated synaptic currents in the rat basolateral amygdala. Eur J Neurosci 30: 800-807.
35. LeDoux J (2003). The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23: 727-738.
36. LeDoux JE, Farb CR, Romanski LM (1991). Overlapping projections to the amygdala and striatum from auditory processing areas of the thalamus and cortex. Neurosci Lett 134: 139-144.
37. Liu W, Yuen EY, Allen PB, Feng J, Greengard P, Yan Z (2006). Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proc Natl Acad Sci USA 103: 18338-18343.
38. Lowell BB, Flier JS (1997). Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Annu Rev Med 48: 307-316.
39. Marowsky A, Yanagawa Y, Obata K, Vogt KE (2005). A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 48: 1025-1037.
40. McCool BA, Chappell A (2007). Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent. Behav Brain Res 178: 70-81.
41. McGaugh JL (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27: 1-28.
42. Menard J, Treit D (1999). Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23: 591-613.
43. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S et al (2005). Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 29: 1214-1224.
44. Oriowo MA, Chapman H, Kirkham DM, Sennitt MV, Ruffolo Jr RR, Cawthorne MA (1996). The selectivity in vitro of the stereo- isomers of the beta-3 adrenoceptor agonist BRL 37344. J Pharmacol Exp Ther 277: 22-27.
45. Ortiz JP, Heinricher MM, Selden NR (2007). Noradrenergic agonist administration into the central nucleus of the amygdala increases the tail-flick latency in lightly anesthetized rats. Neuroscience 148: 737-743.
46. Paxinos G, Watson C (1997). The Rat Brain in Stereotaxic Coordinates, 4th edn Academic Press: San Diego, CA.
47. Pesold C, Treit D (1995). The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671: 213-221.
48. Prut L, Belzung C (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
49. Qu LL, Guo NN, Li BM (2008). Beta1- and beta2-adrenoceptors in basolateral nucleus of amygdala and their roles in consolidation of fear memory in rats. Hippocampus 18: 1131-1139.
50. Rodriguez M, Carillon C, Coquerel A, Le Fur G, Ferrara P, Caput D et al (1995). Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain. Brain Res Mol Brain Res 29: 369-375.
51. Rozec B, Gauthier C (2006). beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111: 652-673.
52. Sanders SK, Shekhar A (1995). Regulation of anxiety by GABAA receptors in the rat amygdala. Pharmacol Biochem Behav 52: 701-706.
53. Selvage DJ, Rivier C (2003). Importance of the paraventricular nucleus of the hypothalamus as a component of a neural pathway between the brain and the testes that modulates testosterone secretion independently of the pituitary. Endocrinology 144: 594-598.
54. Siggins GR, Roberto M, Nie Z (2005). The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther 107: 80-98.
55. Silberman Y, Ariwodola OJ, Weiner JL (2009). Differential effects of GABAB autoreceptor activation on ethanol potentiation of local and lateral paracapsular GABAergic synapses in the rat basolateral amygdala. Neuropharmacology 56: 886-895.
56. Silberman Y, Shi L, Brunso-Bechtold JK, Weiner JL (2008). Distinct mechanisms of ethanol potentiation of local and paracapsular GABAergic synapses in the rat basolateral amygdala. J Pharmacol Exp Ther 324: 251-260.
57. Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O et al (2008). Stimulation of the beta3-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 33: 574-587.
58. Stevens CF, Wang Y (1994). Changes in reliability of synaptic function as a mechanism for plasticity. Nature 371: 704-707.
59. Stevens DR, Kuramasu A, Eriksson KS, Selbach O, Haas HL (2004). Alpha 2-adrenergic receptor-mediated presynaptic inhibition of GABAergic IPSPs in rat histaminergic neurons. Neuropharmacology 46: 1018-1022.
60. Summers RJ, Papaioannou M, Harris S, Evans BA (1995). Expression of beta 3-adrenoceptor mRNA in rat brain. Br J Pharmacol 116: 2547-2548.
61. Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F (2009). The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 59: 221-234.
62. Vrydag W, Michel MC (2007). Tools to study beta3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374: 385-398.
63. Woodruff AR, Sah P (2007). Networks of parvalbumin-positive interneurons in the basolateral amygdala. J Neurosci 27: 553-563.
64. Yurtcu N, Cetin A, Karadas B, Gonca Imir A, Kaya T, Erselcan T et al (2006). Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro. Eur J Pharmacol 530: 263-269.